Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2022

27.01.2021 | Original Article

Simultaneous Examination of Eosinophil Infiltration in Esophageal Mucosa and Muscle in Patients with Achalasia: Direct Biopsy of the Esophageal Muscle at Per-oral Endoscopic Myotomy

verfasst von: Huimin Chen, Lucie F. Calderon, Rushikesh Shah, Wei Zheng, Liang Xia, Wei Wang, Lianyong Li, Baiwen Li, Yue Xue, Steve Keilin, Qiang Cai

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The relationship between eosinophilic esophagitis (EoE) and achalasia is not completely understood. There have been reports of eosinophilic infiltration of all esophageal layers in patients with achalasia. However, a routine endoscopic biopsy of the muscular layer is usually not feasible. We evaluate the safety and efficacy of muscle layer biopsy during per-oral endoscopic myotomy (POEM) as well as the prevalence of eosinophilic infiltration of the esophageal mucosa and muscular layer in patients with achalasia.

Patients and Methods

All enrolled patients had diagnosed achalasia and had simultaneous biopsies of the muscular layer at the middle esophagus and distal esophageal sphincter as well as the mucosal layer of the proximal and distal esophagus during POEM. All POEM procedures took place from August 2018 to December 2018 or September 2019 to November 2019. Various demographic, disease-related, and procedure-related data were collected from chart review. Eosinophilic infiltration in the biopsy specimen was examined.

Key Results

Twenty consecutive patients (65% female, age range: 21–84) with a pre-procedure Eckardt score of >6 were enrolled during the study period, with the duration of their achalasia ranging from 1 to 32 years. Eighteen patients had clinical symptomatic improvement after POEM, as defined by an Eckardt score <3. Endoscopic examination did not reveal any signs of eosinophilic esophagitis. Pathologic examination of biopsies revealed eosinophilic infiltration in three of 20 patients (15%) in the distal esophageal mucosa (all <15 eosinophils/HPF) and none in the proximal esophageal mucosa. There was no eosinophilic infiltration in the distal esophageal sphincter and the middle esophageal muscle. No complication was noted due to muscle biopsy.

Conclusions and Inferences

Submucosal tunneling during POEM provides a safe access for direct esophageal muscle biopsy. This is the first report of the simultaneous biopsy of the esophageal mucosa and muscle in patients with achalasia. Contrary to all previously published studies, the association of esophageal eosinophilic infiltration and achalasia was not observed in this small sample study. Based on our findings, immune or autoimmune reaction rather than direct eosinophilic infiltration in the muscle is more likely the cause of achalasia.
Literatur
1.
Zurück zum Zitat Werner YB, Hakanson B, Martinek J, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019;381:2219–2229CrossRef Werner YB, Hakanson B, Martinek J, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019;381:2219–2229CrossRef
2.
Zurück zum Zitat Goldblum JR, Whyte RI, Orringer MB, et al. Achalasia A morphologic study of 42 resected specimens. Am J Surg Pathol. 1994;18:327–337CrossRef Goldblum JR, Whyte RI, Orringer MB, et al. Achalasia A morphologic study of 42 resected specimens. Am J Surg Pathol. 1994;18:327–337CrossRef
3.
Zurück zum Zitat Tsuboi K, Hoshino M, Srinivasan A, et al. Insights gained from symptom evaluation of esophageal motility disorders: a review of 4,215 patients. Digestion 2012;85:236–242CrossRef Tsuboi K, Hoshino M, Srinivasan A, et al. Insights gained from symptom evaluation of esophageal motility disorders: a review of 4,215 patients. Digestion 2012;85:236–242CrossRef
4.
Zurück zum Zitat Pandolfino JE, Kahrilas PJ, American Gastroenterological A. American Gastroenterological Association medical position statement: clinical use of esophageal manometry. Gastroenterology 2005;128: 207–8. Pandolfino JE, Kahrilas PJ, American Gastroenterological A. American Gastroenterological Association medical position statement: clinical use of esophageal manometry. Gastroenterology 2005;128: 207–8.
5.
Zurück zum Zitat Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996;111:648–654CrossRef Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology 1996;111:648–654CrossRef
6.
Zurück zum Zitat Sodikoff JB, Lo AA, Shetuni BB, et al. Histopathologic patterns among achalasia subtypes. Neurogastroenterol Motil. 2016;28:139–145CrossRef Sodikoff JB, Lo AA, Shetuni BB, et al. Histopathologic patterns among achalasia subtypes. Neurogastroenterol Motil. 2016;28:139–145CrossRef
7.
Zurück zum Zitat de Oliveira Henriques MD, Penido C. Gammadelta T lymphocytes coordinate eosinophil influx during allergic responses. Front Pharmacol. 2012;3:200CrossRef de Oliveira Henriques MD, Penido C. Gammadelta T lymphocytes coordinate eosinophil influx during allergic responses. Front Pharmacol. 2012;3:200CrossRef
8.
Zurück zum Zitat Spechler SJ, Konda V, Souza R. Can eosinophilic esophagitis cause achalasia and other esophageal motility disorders? Am J Gastroenterol. 2018;113:1594–1599CrossRef Spechler SJ, Konda V, Souza R. Can eosinophilic esophagitis cause achalasia and other esophageal motility disorders? Am J Gastroenterol. 2018;113:1594–1599CrossRef
9.
Zurück zum Zitat Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008;135:1526–1533CrossRef Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology 2008;135:1526–1533CrossRef
10.
Zurück zum Zitat Kahrilas PJ, Bredenoord AJ, Fox M, et al. Expert consensus document: advances in the management of oesophageal motility disorders in the era of high-resolution manometry: a focus on achalasia syndromes. Nat Rev Gastroenterol Hepatol. 2017;14:677–688CrossRef Kahrilas PJ, Bredenoord AJ, Fox M, et al. Expert consensus document: advances in the management of oesophageal motility disorders in the era of high-resolution manometry: a focus on achalasia syndromes. Nat Rev Gastroenterol Hepatol. 2017;14:677–688CrossRef
11.
Zurück zum Zitat Eckardt AJ, Eckardt VF. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol. 2011;8:311–319CrossRef Eckardt AJ, Eckardt VF. Treatment and surveillance strategies in achalasia: an update. Nat Rev Gastroenterol Hepatol. 2011;8:311–319CrossRef
12.
Zurück zum Zitat Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71:446–454CrossRef Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71:446–454CrossRef
13.
Zurück zum Zitat Mekaroonkamol P, Li LY, Dacha S, et al. Gastric peroral endoscopic pyloromyotomy (G-POEM) as a salvage therapy for refractory gastroparesis: a case series of different subtypes. Neurogastroenterol Motil. 2016;28:1272–1277CrossRef Mekaroonkamol P, Li LY, Dacha S, et al. Gastric peroral endoscopic pyloromyotomy (G-POEM) as a salvage therapy for refractory gastroparesis: a case series of different subtypes. Neurogastroenterol Motil. 2016;28:1272–1277CrossRef
14.
Zurück zum Zitat Cools-Lartigue J, Chang SY, Mckendy K, et al. Pattern of esophageal eosinophilic infiltration in patients with achalasia and response to Heller myotomy and Dor fundoplication. Dis Esophagus 2013;26:766–775CrossRef Cools-Lartigue J, Chang SY, Mckendy K, et al. Pattern of esophageal eosinophilic infiltration in patients with achalasia and response to Heller myotomy and Dor fundoplication. Dis Esophagus 2013;26:766–775CrossRef
15.
Zurück zum Zitat Nakajima N, Sato H, Takahashi K, et al. Muscle layer histopathology and manometry pattern of primary esophageal motility disorders including achalasia. Neurogastroenterol Motil. 2017;29. Nakajima N, Sato H, Takahashi K, et al. Muscle layer histopathology and manometry pattern of primary esophageal motility disorders including achalasia. Neurogastroenterol Motil. 2017;29.
16.
Zurück zum Zitat Sato H, Nakajima N, Takahashi K, et al. Proposed criteria to differentiate heterogeneous eosinophilic gastrointestinal disorders of the esophagus, including eosinophilic esophageal myositis. World J Gastroenterol. 2017;23:2414–2423CrossRef Sato H, Nakajima N, Takahashi K, et al. Proposed criteria to differentiate heterogeneous eosinophilic gastrointestinal disorders of the esophagus, including eosinophilic esophageal myositis. World J Gastroenterol. 2017;23:2414–2423CrossRef
17.
Zurück zum Zitat Jin H, Wang B, Zhang LL, et al. Activated eosinophils are present in esophageal muscle in patients with achalasia of the esophagus. Med SciMonit. 2018;24:2377–2383 Jin H, Wang B, Zhang LL, et al. Activated eosinophils are present in esophageal muscle in patients with achalasia of the esophagus. Med SciMonit. 2018;24:2377–2383
18.
Zurück zum Zitat Spiegel B, Lacy BE. Negative is positive. Am J Gastroenterol. 2016;111:1505CrossRef Spiegel B, Lacy BE. Negative is positive. Am J Gastroenterol. 2016;111:1505CrossRef
19.
Zurück zum Zitat Cheng E, Zhang X, Huo XF, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 2013;62:824–832CrossRef Cheng E, Zhang X, Huo XF, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 2013;62:824–832CrossRef
20.
Zurück zum Zitat Zhang X, Cheng E, Huo XF, et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS One 2012;7:e50037CrossRef Zhang X, Cheng E, Huo XF, et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS One 2012;7:e50037CrossRef
21.
Zurück zum Zitat Park JY, Zhang X, Nguyen N, et al. Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia. PLoS One 2014;9:e101391CrossRef Park JY, Zhang X, Nguyen N, et al. Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia. PLoS One 2014;9:e101391CrossRef
22.
Zurück zum Zitat Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol. 2013;13:9–22CrossRef Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol. 2013;13:9–22CrossRef
23.
Zurück zum Zitat Hejazi RA, Reddymasu SC, Sostarich S, et al. Disturbances of esophageal motility in eosinophilic esophagitis: a case series. Dysphagia 2010;25:231–237CrossRef Hejazi RA, Reddymasu SC, Sostarich S, et al. Disturbances of esophageal motility in eosinophilic esophagitis: a case series. Dysphagia 2010;25:231–237CrossRef
24.
Zurück zum Zitat Nennstiel S, Bajbouj M, Becker V, et al. High-resolution manometry in patients with eosinophilic esophagitis under topical steroid therapy-a prospective observational study (HIMEOS-study). Neurogastroenterol Motil. 2016;28:599–607CrossRef Nennstiel S, Bajbouj M, Becker V, et al. High-resolution manometry in patients with eosinophilic esophagitis under topical steroid therapy-a prospective observational study (HIMEOS-study). Neurogastroenterol Motil. 2016;28:599–607CrossRef
Metadaten
Titel
Simultaneous Examination of Eosinophil Infiltration in Esophageal Mucosa and Muscle in Patients with Achalasia: Direct Biopsy of the Esophageal Muscle at Per-oral Endoscopic Myotomy
verfasst von
Huimin Chen
Lucie F. Calderon
Rushikesh Shah
Wei Zheng
Liang Xia
Wei Wang
Lianyong Li
Baiwen Li
Yue Xue
Steve Keilin
Qiang Cai
Publikationsdatum
27.01.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2022
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06827-4

Weitere Artikel der Ausgabe 1/2022

Digestive Diseases and Sciences 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.